Doximity Q4 Profit Plunges 70% on Soaring Expenses; FY27 Guidance Misses Estimates
DOCS is trading near its 52-week low of $20.55 (7.8% below the low) on elevated volume (3.7× avg).
Summary
Doximity reported a significant decline in fiscal fourth-quarter profit, falling to $19.1 million from $62.5 million a year prior, representing a nearly 70% drop. Adjusted earnings per share of $0.26 also missed analyst estimates of $0.28. This profit decline was primarily driven by a substantial increase in operating expenses, which rose to $101.1 million from $75.1 million. Furthermore, the company's fiscal year 2027 revenue guidance ($664M-$676M) and Q1 revenue guidance ($151M-$152M) both fell short of analyst expectations. While revenue slightly beat estimates, the significant profit decline and weak future outlook are highly material and likely to exert substantial downward pressure on the stock, especially as it is already trading near its 52-week low. Traders will be closely watching the stock's reaction and any subsequent analyst revisions.
At the time of this announcement, DOCS was trading at $18.95 on NYSE in the Technology sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $20.55 to $76.51. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.